Erectile dysfunction (ED) has evolved from a taboo subject whispered behind closed doors to a mainstream medical concern openly discussed in both clinics and commercials. Defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance, ED is now recognized not only as a quality-of-life issue but also as a marker […]

Sexual dysfunction (SD) is a frequently underestimated complication of multiple sclerosis (MS), yet it affects nearly two-thirds of patients across their disease trajectory. Its impact is not confined to the bedroom; it extends into domains of mood, self-esteem, relationships, and overall quality of life. Importantly, SD is not a uniform entity. It encompasses primary neurological […]

Erectile dysfunction (ED) has long been managed with a one-size-fits-all mentality, dominated by the use of phosphodiesterase type 5 (PDE5) inhibitors such as sildenafil. While these agents revolutionized the field by providing a safe, effective, and convenient oral therapy, a growing body of evidence suggests that monotherapy often leaves many patients dissatisfied. Clinical realities—ranging from […]